Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Role of Serum Mmp-9 Levels and Vitamin D Receptor Polymorphisms in the Susceptibility to Coronary Artery Disease: An Association Study in Iranian Population Publisher Pubmed



Moradi N1 ; Fadaei R2 ; Ahmadi R1 ; Mohammad MH1 ; Shahmohamadnejad S3 ; Tavakoliyaraki M1 ; Aghajani H4 ; Fallah S1, 5
Authors

Source: Gene Published:2017


Abstract

Background Data concerning the association of serum levels of vitamin D and metalloproteinases and vitamin D receptor gene polymorphism with coronary artery disease (CAD) is not fully demonstrated. The present study aimed to evaluate the association of vitamin D receptor gene polymorphism, serum levels of 25(OH) vitamin D and metalloproteinase-9 (MMP-9) with CAD. Methods 104 patients with CAD and 69 Non-CAD subjects were included in current study. Vitamin D receptor genotypes were determined by PCR-RFLP method. The 25(OH) vitamin D and MMP-9 were determined by ELISA assay. Results There was a significant reduction of vitamin D in CAD patients (P = 0.001). The metalloproteinase 9 levels of CAD patient was increased significantly compared with controls (P = 0.001). A significant reverse correlation also was found between MMP-9 concentration and 25(OH) vitamin D levels of patients (r = − 0.28, P < 0.001). In addition, we identified that VDR gene FokI polymorphism was significantly associated with CAD. Furthermore, MMP-9 levels of CAD patients with ff genotype of FokI polymorphism was higher significantly than patients with FF and Ff genotypes. It has been also found that MMP-9 levels of CAD patients with ff genotype of FokI polymorphism was higher significantly than patients with FF and Ff genotypes. Conclusion Our results indicated that 25(OH) vitamin D, MMP-9 levels and VDR gene FokI polymorphisms play a critical role in the development and progression of CAD and may contribute to susceptibility to CAD in Iranian populations. © 2017
Other Related Docs
6. Vitamin D Receptor Gene Polymorphisms and the Risk of Metabolic Syndrome (Mets): A Meta-Analysis, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)